$1.020
-0.038 (-3.77%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CGTX Prediction & Forecast by Similar Chart Analysis
Alphio's CGTX stock price prediction model matches the current Cognition Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.01 (-1.06%). The 1-week path is $1.01 (-1.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Cognition Therapeutics Inc Stock?
Cognition Therapeutics Inc (CGTX) appears to be a good buy right now, primarily due to its narrowed net loss of $3.9 million in Q2 2026, down from $6.7 million a year earlier, indicating improved financial management. Additionally, the stock has shown a 14.66% increase over the past 20 days, suggesting a positive momentum. However, the main risk is its year-to-date decline of 30.61%, which reflects market volatility and investor sentiment concerns.
CGTX stock price ended at $1.02 on Friday, after losing -3.77%
Cognition Therapeutics Inc (CGTX) last closed at $1.02, losing -3.77%. These facts feed the 1-day and 1-week CGTX price prediction above.
Forecast Drivers
Cognition Therapeutics Inc (CGTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CGTX, ranked by similarity.
Seasonality analysis for CGTX
Historically the probability of a positive August return for CGTX is 25.40%. January offers the highest probability of a positive month at 52.46%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CGTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.68 | $0.71 | $0.75 | -30.16% |
| Sep 2026 | $0.56 | $0.62 | $0.76 | -38.86% |
| Oct 2026 | $0.53 | $0.64 | $0.76 | -37.55% |
| Nov 2026 | $0.77 | $0.79 | $0.80 | -22.58% |
| Dec 2026 | $0.76 | $0.79 | $0.86 | -22.58% |
In 2026, Cognition Therapeutics Inc (CGTX) is projected to range from $0.53 to $0.86.
Cognition Therapeutics Inc 2026 monthly forecast
In Aug 2026, Cognition Therapeutics Inc is projected to average $0.71, with a low of $0.68 and high of $0.75.
In Sep 2026, Cognition Therapeutics Inc is projected to average $0.62, with a low of $0.56 and high of $0.76.
In Oct 2026, Cognition Therapeutics Inc is projected to average $0.64, with a low of $0.53 and high of $0.76.
In Nov 2026, Cognition Therapeutics Inc is projected to average $0.79, with a low of $0.77 and high of $0.80.
In Dec 2026, Cognition Therapeutics Inc is projected to average $0.79, with a low of $0.76 and high of $0.86.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.